Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K161634
    Device Name
    IPS CaseDesigner
    Manufacturer
    Date Cleared
    2016-11-10

    (149 days)

    Product Code
    Regulation Number
    892.2050
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K052424, K111641

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    IPS CaseDesigner is indicated for use as a software and image segmentation system for the transfer of imaging information from a scanner such as a CT scanner. It is also indicated to support the diagnostic and treatment planning process of cranio-maxillofacial procedures. IPS CaseDesigner facilitates the service offering of individualized surgical aids.

    Device Description

    The IPS CaseDesigner software is a tool for the virtual planning of orthognathic surgery. The user is a (oral and maxillofacial) surgeon who needs to plan an orthognathic surgery, and will use the software to plan the osteotomy (bone cutting). This allows the surgeon to re-position the digitally cut pieces in the desired alignment and allows the visualization of how the patient aspect will look like, through soft tissue simulation. The software supports various types of osteotomy procedures (Le Fort I, Sagittal Split, Ramus and Chin).The selection of the appropriate osteotomy procedure for each patient case is at the discretion of the clinician.

    The IPS CaseDesigner is a 3D image-based environment that allows the clinician to visualize a patient's anatomy. The creation of the 3D augmented patient model is derived from CBCT (Cone-Beam CT) data (DICOM). This allows the clinician virtually plan and simulate a craniomaxillofacial surgery. The IPS CaseDesigner software has the capability to save a surgical splint file that the clinician can send to the manufacturing facility for surgical splint creation based on the CBCT Data. The software does not have any functionality for designing.

    AI/ML Overview

    The provided text describes the 510(k) premarket notification for the "IPS CaseDesigner" device (K161634). However, it does not contain detailed information about specific acceptance criteria and the results of a study proving the device meets those criteria.

    The document states:

    • "Performance Data VII. The following performance data were provided or relied upon in support of the substantial equivalence determination."
    • "Software Validation: Software verification and validation testing was conducted on the subject device and documentation was provided as recommended by FDA's Guidance for Industry and FDA Staff, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices"."

    This indicates that performance data and software validation were submitted to the FDA, but the details of these tests, including specific acceptance criteria, sample sizes, ground truth establishment, or clinical study results (like MRMC studies or standalone performance), are not present in the provided excerpt.

    Therefore, I cannot provide a table of acceptance criteria and reported performance, nor can I answer questions about sample sizes, data provenance, expert involvement, adjudication methods, MRMC studies, standalone performance, or ground truth details. That information would typically be found in the detailed performance data or a separate study report, which is not included in this FDA 510(k) summary.

    Ask a Question

    Ask a specific question about this device

    K Number
    K113732
    Manufacturer
    Date Cleared
    2012-05-07

    (140 days)

    Product Code
    Regulation Number
    892.1750
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K101627, K052424

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    iPlan's indications for use are the viewing, presentation and documentation of medical imaging, including different modules for image processing, image fusion, atlas assisted visualization and segmentation, intraoperative functional planning where the output can be used e.g. with stereotactic image guided surgery or other devices for further processing and visualization.

    Example procedures include but are not limited to:

    • Planning and simulation of cranial surgical procedures such as tumor resection, shunt placement, minimal-invasive stereotactic interventions, biopsy, planning and simulation of trajectories for stimulation and electrode recording
    • ENT procedures such as sinus surgery, tumor surgery
    • Spine procedures such as tumor surgery, pedicle screw planning, vertebroplasty planning
    • iPlan View is an application which is intended to be used for reviewing existing treatment plans
    • Planning and simulation of cranio-maxillofacial procedures

    Typical users of iPlan are medical professionals, including but not limited to surgeons and radiologists.

    Device Description

    iPlan is a software based treatment planning application providing functionalities like viewing, processing and documentation of medical data including different modules for image preparation, image fusion, image segmentation where the result is a treatment plan that can be used e.g. for stereotactic and/or image guided surgery.

    AI/ML Overview

    The provided 510(k) summary for iPlan focuses on demonstrating substantial equivalence to predicate devices through technical characteristics, intended use, and non-clinical performance data. It does not provide detailed acceptance criteria or a specific study proving the device meets those criteria in the format typically associated with AI/ML device performance evaluations (e.g., sensitivity, specificity, AUC).

    However, I can extract the information related to non-clinical performance data and application performance testing which served as the basis for the FDA's substantial equivalence determination for this software planning application.

    Here's a breakdown of the requested information based on the provided text:

    1. A table of acceptance criteria and the reported device performance

    The document does not explicitly state quantitative acceptance criteria (e.g., minimum sensitivity, specificity, accuracy) for the device's performance. Instead, it relies on demonstrating equivalence to predicate devices and adherence to internal standards and specifications.

    Acceptance Criterion (Implicit)Reported Device Performance
    Usability Validation: The device is usable and meets user needs."Usability workshops were performed with prototype versions of the software which has no relevant user interface differences to the final version and is therefore equivalent to the final version in respect to the usability validation. Moreover an Expert Group Review has worked with Brainlab in order to tailor the existing iPlan planning functionalities to the specific needs of CMF surgeons."
    Functional Equivalence: The software performs its intended functions correctly and reliably."On different levels of development (module, subsystem, system) specific bench and integration tests were conducted."
    "Internal standards were tested and documented as conformance report, environment compatibility and interfaces."
    "Compatibility with previous version and comparable workflows to predicate devices were documented in corresponding review protocols."
    Clinical Relevance/Safety: The device's output is safe and effective for its indicated uses."The clinical evaluation has been based on literature studies." (This suggests reliance on existing clinical knowledge and predicate device performance rather than a new clinical trial for iPlan itself).
    Substantial Equivalence: The device is as safe and effective as legally marketed predicate devices.The overall conclusion of the 510(k) summary is that the submitted information... is complete and supports a substantial equivalence decision. The FDA's letter concurs with this, stating that the device is "substantially equivalent... to legally marketed predicate devices."

    2. Sample size used for the test set and the data provenance

    The document does not specify a "test set" in the context of a dataset for a performance study.

    • For Usability Workshops: The sample size (number of participants) is not mentioned. The workshops were likely conducted on prototypes.
    • For Application Performance Testing: The sample size of test cases or data used during bench and integration tests is not specified.
    • Data Provenance: Not applicable in the context of a dataset for a performance study.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This is not directly applicable as there isn't a traditional "test set" with ground truth established by experts in the context of a performance study for this type of device described.

    • For the Expert Group Review in usability: The number of experts is not specified, but they are described as working with Brainlab "to tailor the existing iPlan planning functionalities to the specific needs of CMF surgeons." Their qualifications are implicitly that they are CMF (Cranio-Maxillofacial) surgeons.

    4. Adjudication method for the test set

    Not applicable, as a dedicated "test set" for performance evaluation with an adjudication process is not described.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    No MRMC comparative effectiveness study is mentioned. The device is a planning application, and the evaluation focuses on its functional correctness, usability, and equivalence to predicates, not on AI-assisted diagnostic improvement for human readers.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This refers to the software performing its functions without human interaction. The "Application performance testing" ("bench and integration tests") would implicitly cover the standalone performance of the algorithms and modules within iPlan to ensure they meet internal standards. However, specific metrics are not provided. iPlan is described as a "software based treatment planning application," implying it's a tool for medical professionals, not a fully autonomous diagnostic or therapeutic AI.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    For the "Application performance testing," the ground truth would be the expected output or behavior of the software modules based on their specifications and internal standards. This is typically established through:

    • Functional Specifications: Defining what each module (e.g., Image Fusion, Object Creation) is supposed to do.
    • Reference Data/Known Inputs: Using synthetic or previously validated medical data where the "correct" output of a segmentation, fusion, or trajectory calculation is known or can be analytically derived.
    • Comparison to Predicate Devices: Ensuring that functionally similar modules perform comparably to predicate devices.

    8. The sample size for the training set

    This document does not describe the development of an AI/ML model that would typically have a "training set." iPlan is presented as a software application with various processing and visualization functionalities.

    9. How the ground truth for the training set was established

    Not applicable, as a "training set" for an AI/ML model is not mentioned in this context.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1